Valuation: Amerise Biosciences Limited

Market Cap	55.5M 578K 504K 476K 432K 810K 814K 5.7M 2.2M 28.22M 2.17M 2.12M 90.79M	P/E 2025	1,056x	P/E 2026	242x
Enterprise Value	49.58M 517K 451K 425K 386K 724K 727K 5.1M 1.97M 25.21M 1.94M 1.9M 81.11M	EV / Sales 2025	31.9x	EV / Sales 2026	13x
Free-Float	64.18%	Yield 2025 *	-	Yield 2026	-

* Estimated data More valuation ratios

Chart: Amerise Biosciences Limited

Dynamic Chart

Latest news: Amerise Biosciences Limited

08-03	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-02	Amerise Biosciences appoints Albert Hines as CFO	RE
02-02	Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026	CI
02-02	Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026	CI
11-05	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
24/09/25	Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025	CI
24/07/25	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
19/05/25	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
03/02/25	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
03/02/25	Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director	CI
27/01/25	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI

More news

Quotes and Performance

1 day	+5.00%
1 week	+1.20%
Current month	+5.00%
1 month	-1.18%
3 months	-6.67%
6 months	+23.53%
Current year	+37.70%

More quotes

Price Extremes

1 week	0.77	0.84
1 month	0.77	0.86
Current year	0.5	1.03
1 year	0.5	1.03
3 years	0.5	1.45
5 years	0.5	2.73
10 years	0.5	2.73

More quotes

Managers and Directors: Amerise Biosciences Limited

Manager	Title	Age	Since
Albert Hines DFI	Director of Finance/CFO	-	01/02/2026
Soni Pandiya CMP	Compliance Officer	-	14/04/2026

Director	Title	Age	Since
Manisha Maneklal Patel BRD	Director/Board Member	57	23/06/2019
Niraj Vijaybbai Vaghela BRD	Director/Board Member	29	22/07/2022
Albert Hines BRD	Director/Board Member	-	01/02/2026

More insiders

Shell Companies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMERISE BIOSCIENCES LIMITED	+5.00%	+1.20%	+20.00%	+31.25%	578K
CHURCHILL CAPITAL CORP XI	+6.83%	+4.71%	-	-	719M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.05%	+0.07%	-	-	648M
CENTIEL AG	+2.91%	+9.28%	+299.50%	-72.82%	630M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	0.00%	-	-	601M
CHURCHILL CAPITAL CORP XII	-0.98%	-1.25%	-	-	591M
CANTOR EQUITY PARTNERS IV, INC.	-0.29%	-0.14%	+1.47%	-	591M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.36%	-1.68%	-	-	550M
CHURCHILL CAPITAL CORP XIII	0.00%	0.00%	-	-	518M
Average	+1.44%	+1.35%	+106.99%	-20.79%	538.7M
Weighted average by Cap.	+1.18%	+1.55%	+155.23%	-72.73%

See all sector performances

Financials

	2025	2026
Net sales	1.88M 19.59K 17.08K 16.13K 14.65K 27.45K 27.56K 193K 74.57K 956K 73.6K 71.97K 3.08M	2.55M 26.6K 23.19K 21.9K 19.89K 37.26K 37.41K 262K 101K 1.3M 99.91K 97.69K 4.17M
Net income	57K 594.03 517.99 489.11 444.14 832.14 835.62 5.86K 2.26K 28.98K 2.23K 2.18K 93.25K	161K 1.68K 1.46K 1.38K 1.25K 2.35K 2.36K 16.55K 6.39K 81.85K 6.3K 6.16K 263K
Net Debt	-222K -2.31K -2.02K -1.9K -1.73K -3.24K -3.25K -22.82K -8.81K -113K -8.69K -8.5K -363K	-5.92M -61.69K -53.79K -50.79K -46.12K -86.41K -86.77K -608K -235K -3.01M -232K -227K -9.68M